SkinIO Completes Smart Health Innovation Lab Residency Program, Reinforcing 'Market-Readiness' for Skin Cancer Screening Platform
During 'iLab' certification process, SkinIO detected skin cancer risk in several patients, further validating the technology
LANCASTER, Pa., Sept. 28, 2022 /PRNewswire-PRWeb/ -- SkinIO, a virtual skin cancer screening platform that allows anyone, anywhere to perform a full-body skin exam using their smartphone, is the latest graduate of the Smart Health Innovation Lab (iLab), a market adoption accelerator for healthcare technologies.
SkinIO has now passed key quality assurance and efficacy standards needed to increase adoption of its technology. SkinIO meets users where they are, providing on-site skin screenings in 10 minutes and allowing users to scan and securely map their skin at home with the SkinIO smartphone app. SkinIO photos and data are securely sent to dermatologists to remotely review and recommend appropriate follow-up care.
During a pilot program with local employers, the company's detection protocol discovered skin cancer risk in several patients. SkinIO also helped connect users with medical professionals when needed. Working with employers, physicians, and healthcare organizations, SkinIO plans to further align with payors as the value-based care market begins to take shape.
SkinIO is the third company to graduate through the iLab's state-of-the-art innovation "immersion" experience, in which providers, payors, investors, patients, and clinical experts work together to test and enhance products before they are fully introduced to the healthcare market. The focus of this year's cohort was teledermatology and improving access to skin cancer screening at a time when preventive check-ups have declined, mostly due to the pandemic.
"Our iLab graduates are solving real-world problems, like the lack of accessible, easy-to-use skin cancer screening tools that can save lives," said Kim Ireland, CEO, Smart Health Innovation Lab. "The iLab is proving to be a premier program for empowering early-stage technologies like SkinIO, using the strength of our alliances across the healthcare landscape to bring healthcare technology to the doctor's office and patients."
SkinIO leveraged iLab's extensive network and bench of clinical, operational, and payor expertise to enhance its product's features and open the doors to new customers. In May, SkinIO collaborated with several Lancaster-based employers to conduct a pilot program. The program helped increase screening numbers among employees of those companies, 43% of whom had never had a formal skin exam before. Participants responded with a 95% "very satisfied" or "satisfied" rate.
"We were able to pressure-test our technology in a setting that allowed for iterative feedback from end users – patients, employers, payors, and clinical leaders with decades of experience – and hone our go-to-market strategy in a way that accelerates our growth timeline," said Kyoko Crawford, CEO, SkinIO. "Smartphones and digital tools are increasingly critical for expanding access to specialty care like dermatology – access that past generations simply haven't had. We plan to make virtual skin screening, and the deployment of AI to analyze data, a standard for care."
The Smart Health Innovation Lab focuses on early-stage technologies and diagnostics with commercial viability and unmet demand in the market. In previous years, iLab has supported companies like NeuroFlow, Emovi, and OneOme, serving as a testing ground for new applications and promoting interoperability in various healthcare settings. Schedules and timelines for the next cohort will be available for applicants in the late fall 2022.
About Smart Health Innovation Lab
Smart Health Innovation Lab, located in Lancaster, Pa., is a market adoption accelerator built for testing, certifying, and advancing new healthcare technologies. At the lab, payors, providers, and technology companies work together in a unique collaboration to validate and integrate healthcare innovations into the healthcare marketplace. Founded by Aspire Ventures, Capital Blue Cross, Clio Health, and Penn Medicine Lancaster General Health, the Smart Health Innovation Lab brings together different healthcare stakeholders to achieve a common goal: improving the health of our communities through new technologies that improve the patient and provider experience, lower cost of care, and improve health outcomes. For more information, visit http://www.smarthealthinnovationlab.com.
About SkinIO
SkinIO is a HIPAA-compliant, AI-driven, virtual skin cancer screening platform that allows anyone, anywhere to perform a skin exam in just 10 minutes using their smartphone. SkinIO images are reviewed remotely by expert dermatologists, users receive their results by email in just a few days, and they are connected to care if they require in-person follow-up. For more information, visit https://skinio.com/.
###
Media Contact
Anthony Stipa, Quickstudy PR, 1 610-420-1724, [email protected]
SOURCE Quickstudy PR
Share this article